Injection sites: Three primary sites work for subcutaneous delivery
Overall, correlations among the five PerfOs were slightly higher at follow-up than at baseline
Comparison of self-report data with EHRs Research participants were able to share EHR data with 23andMe through Apple HealthKit (Methods)
GLP-1s are designed to suppress appetite, but nursing mothers should be consuming more calories, not less, to support milk production
They are now commonly used when: Metformin alone is no longer enough Weight gain is contributing to worsening glucose control There is a need to minimise hypoglycaemia risk Someone has existing cardiovascular disease or multiple risk factors For many people, GLP-1 therapy can delay or reduce the need for insulin, or allow insulin doses to be kept lower and safer
But laboratory testing only matters if you can confirm the documentation belongs to the batch you received